Citadel Advisors’s HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HPX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100,791
Closed -$8K 14058
2022
Q2
$8K Sell
100,791
-734
-0.7% -$112 ﹤0.01% 12637
2022
Q1
$18K Buy
101,525
+1,511
+2% +$517 ﹤0.01% 13281
2021
Q4
$54K Sell
100,014
-108
-0.1% -$72 ﹤0.01% 13212
2021
Q3
$65K Sell
100,122
-418
-0.4% -$311 ﹤0.01% 13216
2021
Q2
$88K Sell
100,540
-125
-0.1% -$99 ﹤0.01% 13020
2021
Q1
$82K Buy
+100,665
New +$138K ﹤0.01% 12622

Other funds holding HPX.WS

Citadel Advisors's HPX.WS Position: Q3 2022 in Review

Citadel Advisors sold out of HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HPX.WS) in Q3 2022, closing a stake of 100,791 shares — an estimated $8K sold.

Citadel Advisors first reported a position in HPX.WS in Q1 2021 and held it in 6 quarters. The position peaked at $88K in Q2 2021. 39 funds tracked by Wall St. Rank hold HPX.WS as of Q3 2022.

  • Citadel Advisors reported no remaining HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 100,791 HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $8K.
  • Citadel Advisors first reported a position in HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 6 quarters.
  • Citadel Advisors's HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $88K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.